The popular antidepressant fluoxetine, appointed to restore the function of patients after stroke, is ineffective, this was stated by researchers from the University of Edinburgh. They obtained evidence of the futility of the drug published the journal The Lancet.
Scientists denied the use of popular antidepressant fluoxetine used for faster recovery after a stroke. They did not find improvement form from participants who took this drug for six months.
Experts at Edinburgh University followed condition 3 of 127 people over the age of 18, undergoing rehabilitation after stroke. They all happened after the brain hemorrhage had neurological disorders. Scientists have divided them into groups, one of which ate every day for 20 milligrams of fluoxetine, while the second received a placebo.
Utilizing for evaluating the effectiveness of drug Rankin scale, the researchers found no differences between participants in the two groups.
“Fluoxetine has not helped to improve the function of limbs in patients after stroke. They less frequently observed symptoms of depression, but also registered a 1.41 percent more cases of fractures,” – said the authors of the project.
Prior to this it was argued that patients after stroke the antidepressant fluoxetine may help to restore the physical form due to the strengthening of the process of neurogenesis and also the stimulating effect of the drug. But in the new study, the researchers summed up the futility of the use of fluoxetine for physical recovery of patients after stroke.
Earlier Magicforum wrote that the development of stroke and dementia can contribute to d Sol.